Rethinking Apathy and Gait: Clinical Implications for Dementia and Integrated Care.
Key claim: Apathy and gait slowing serve as early, observable clinical markers that frequently precede overt dementia and can enhance screening and integrated care strategies.
Abstract
There is increasing recognition that a broader array of biological changes may contribute to the clinical expression of cognitive decline. As such, an emerging and often overlooked consideration in dementia is apathy, gait dysfunction, motoric-cognitive risk syndrome, and their interplay. Broadly, apathy, gait dysfunction, and motoric-cognitive risk may reflect changes across multiple physiological and neural systems acting as clinical markers bridging normal aging and overt dementia, thereby offering a framework to better understand and monitor dementia risk, management, and prognosis. This article synthesizes some key findings in this emerging field, highlighting their relevance to integrated screening and intervention strategies. The authors emphasize the clinical importance of recognizing apathy and gait slowing as early, observable features that often precede overt cognitive impairment and are commonly encountered across routine clinical settings.
Why this matters
Apathy and gait slowing serve as early, observable clinical markers that frequently precede overt dementia and can enhance screening and integrated care strategies.